April 2020 • PharmaTimes Magazine • 4-5
16.
On track?
Is the NHS Long Term Plan still on track? The team at Wilmington Healthcare explore the latest developments and what they mean for pharma
22.
Unlocking value
Lev Gerlovin and Pascale Diesel look at how cell and gene therapies are driving new deals in life sciences
Nicola Boyd argues that we should be realistic about what the NICE Review will deliver
Gustaf Duhs considers the legal issues surrounding the rapidly expanding field of digital health
Hilary Thomas considers the progress and challenges in reaping the benefits of genomics
28.
Pitch Perfect
Mike Dixon discusses two initiatives trying to help identify best practice guidance for all stakeholders in the pitch process
Stephen Nabarro, head of clinical operations and data management at Cancer Research UK Centre for Drug Development, talks to PharmaTimes about his role in cancer research
38.
Appointments
Ingunn Westerheim shares her experiences of life with a rare bone disorder